期刊文献+

玻璃体腔注射曲安奈德治疗各种类型黄斑水肿的疗效观察

Therapeutic effect of intravitreal Triamcinolone Acetonide for macular edema
下载PDF
导出
摘要 目的观察玻璃体腔注射曲安奈德治疗各种类型黄斑水肿的疗效。方法比较63例确诊为黄斑水肿的患者(87只眼)玻璃体腔注射曲安奈德治疗前及治疗后2,4,8,12周最佳矫正视力(BCVA)、中心视网膜厚度(CMT)、眼压的变化。结果治疗后2,4,8,12周与术前比较BCVA提高、CMT显著下降、眼压明显升高,差异均具有统计学意义(P<0.05)。结论玻璃体腔注射曲安奈德治疗各种类型黄斑水肿疗效确切,但其并发症不容忽视。 Objective To evaluate the effectivencess of intravitreal triamcinolone acetonide(TA)for macular edema.Methods In 63 cases(87eyes)for intravitreal TA injection were analyzed.We compare the change of best corrected visual acuity(BCVA),central macular thickness(CMT)and intraocular pressure at follow 2-week,4-week,8-week,12-week follow-up.Results At 2-week,4-week,8-week,12-week,the increases of BCVA was significant;the reduction of macular edema was insignificant;intraocular pressure was significantly higher.(P〈0.05).Conclusions Intravitreal ttiamcinolone acetonide was effective remedy for macular edema.,but complication could not ignorance.
出处 《基层医学论坛》 2016年第7期868-870,共3页 The Medical Forum
关键词 黄斑水肿 曲安奈德 玻璃体腔注射 疗效 并发症 Macular edema Triamcinolone Acetonide Intravitreal injection Curative effect Complication
  • 相关文献

参考文献6

二级参考文献76

  • 1王景昭.黄斑水肿的药物和手术治疗[J].中华眼底病杂志,2004,20(5):316-319. 被引量:26
  • 2常青,王文吉.玻璃体内注射曲安奈德治疗黄斑水肿的临床疗效观察[J].中华眼底病杂志,2005,21(4):209-212. 被引量:15
  • 3Klein R,Klein BE,Moss SE.Visual impairment in diabetes[J].Ophthalmology,1984,91:1-9.
  • 4Early Treatment Diabetic Retinopathy Study Reseereh Group.Early treatment diabetic retinopathy study report number 1.Photocoagulation for diabetic macular edema[J].Arch Ophthalmol,1985,103(12):1796-1806.
  • 5Arevalo JF,Fromow-Guerra J,Quiroz-Mercado H,et al.Primary intravitreal bevacizumab (Avastin) for diabetic macular edema:results from the Pan-American Collaborative Retina Study Group at 6-month follow-up[J].Ophthalmology,2007,114:743-750.
  • 6Jonas JB,Sofker A.Intraocular injection of crystalline cortisone ss adjunctive treatment of diabetic macular edema[J].Am J Ophthalrnol,2001,132:425-7.
  • 7Jonas JB.Intravitreal triamcinolone acetonide for diabetic retinopathy[J].Dev Ophthalmol,2007,39:96-110.
  • 8Nguyen QD,Shah SM,Van Anden E,et al.Supplemental oxygen improves diabetic macular edema:a pilot study[J].Invest Ophthalmol Vis Sct,2004,45:617-624.
  • 9Ferrara N.Vascular endothelial growth factor:basic science and clinical progress[J].Endocr Rev,2004,25:581-611.
  • 10Arevalo JF,Fromow-Guerra J,Quiroz-Mercado H,et al.Primary intravitreal bevacizumab (Avastin) for diabetic macular edema results from the Pan-American Collaborative Retina Study Group at 6-month follow-up[J].Ophthalmology,2007,114:743-750.

共引文献157

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部